BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 27610572)

  • 1. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.
    Singer M; Wang C; Cong L; Marjanovic ND; Kowalczyk MS; Zhang H; Nyman J; Sakuishi K; Kurtulus S; Gennert D; Xia J; Kwon JYH; Nevin J; Herbst RH; Yanai I; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Cell; 2016 Sep; 166(6):1500-1511.e9. PubMed ID: 27610572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
    Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
    Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
    Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
    J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR4A transcription factors limit CAR T cell function in solid tumours.
    Chen J; López-Moyado IF; Seo H; Lio CJ; Hempleman LJ; Sekiya T; Yoshimura A; Scott-Browne JP; Rao A
    Nature; 2019 Mar; 567(7749):530-534. PubMed ID: 30814732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOX is a critical regulator of tumour-specific T cell differentiation.
    Scott AC; Dündar F; Zumbo P; Chandran SS; Klebanoff CA; Shakiba M; Trivedi P; Menocal L; Appleby H; Camara S; Zamarin D; Walther T; Snyder A; Femia MR; Comen EA; Wen HY; Hellmann MD; Anandasabapathy N; Liu Y; Altorki NK; Lauer P; Levy O; Glickman MS; Kaye J; Betel D; Philip M; Schietinger A
    Nature; 2019 Jul; 571(7764):270-274. PubMed ID: 31207604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.
    Mohme M; Schliffke S; Maire CL; Rünger A; Glau L; Mende KC; Matschke J; Gehbauer C; Akyüz N; Zapf S; Holz M; Schaper M; Martens T; Schmidt NO; Peine S; Westphal M; Binder M; Tolosa E; Lamszus K
    Clin Cancer Res; 2018 Sep; 24(17):4187-4200. PubMed ID: 29444930
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromatin states define tumour-specific T cell dysfunction and reprogramming.
    Philip M; Fairchild L; Sun L; Horste EL; Camara S; Shakiba M; Scott AC; Viale A; Lauer P; Merghoub T; Hellmann MD; Wolchok JD; Leslie CS; Schietinger A
    Nature; 2017 May; 545(7655):452-456. PubMed ID: 28514453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral Tcf1
    Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
    Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
    Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
    J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of B7.1-modified tumor to evoke full activation of CD8+ tumor-infiltrating lymphocytes in the central nervous system: prevention of parental tumor growth in the subcutaneous environment.
    Ando H; Saio M; Tamakawa N; Ohe N; Nakayama T; Yu H; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
    J Neurosurg; 2002 Aug; 97(2):432-40. PubMed ID: 12186473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA-3 regulates the homeostasis and activation of CD8+ T cells.
    Tai TS; Pai SY; Ho IC
    J Immunol; 2013 Jan; 190(1):428-37. PubMed ID: 23225883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
    Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Fibroblast-Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor-Infiltrating T Cells and Plays a Role in T-cell Exhaustion.
    Chen QY; Li YN; Wang XY; Zhang X; Hu Y; Li L; Suo DQ; Ni K; Li Z; Zhan JR; Zeng TT; Zhu YH; Li Y; Ma LJ; Guan XY
    Cancer Res; 2020 Dec; 80(24):5583-5596. PubMed ID: 33093168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8
    Yonekura S
    Anticancer Res; 2022 Jan; 42(1):511-517. PubMed ID: 34969761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
    Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
    Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced CD5 on CD8
    Alotaibi F; Vincent M; Min WP; Koropatnick J
    Front Immunol; 2020; 11():584937. PubMed ID: 33584650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.
    Woroniecka K; Chongsathidkiet P; Rhodin K; Kemeny H; Dechant C; Farber SH; Elsamadicy AA; Cui X; Koyama S; Jackson C; Hansen LJ; Johanns TM; Sanchez-Perez L; Chandramohan V; Yu YA; Bigner DD; Giles A; Healy P; Dranoff G; Weinhold KJ; Dunn GP; Fecci PE
    Clin Cancer Res; 2018 Sep; 24(17):4175-4186. PubMed ID: 29437767
    [No Abstract]   [Full Text] [Related]  

  • 20. Exhaustion-associated regulatory regions in CD8
    Mognol GP; Spreafico R; Wong V; Scott-Browne JP; Togher S; Hoffmann A; Hogan PG; Rao A; Trifari S
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2776-E2785. PubMed ID: 28283662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.